Prevention of atrial fibrillation with SGLT2 inhibitors across the spectrum of cardiovascular disorders: a meta-analysis of randomised controlled trials
Event:
ESC Congress 2025
Topic:
Prevention
Session:
Antiarrhythmic and upstream pharmacological therapy in atrial fibrillation